Medical Communications
New drug application for AstraZeneca’s Lynparza given more time by FDA
December 15, 2022 Medical Communications
AstraZeneca and its US collaborator, Merck, have announced that the FDA is allowing more time for the review of the …
GlaxoSmithKline enter into $3.3bn pact with Wave Life Sciences over oligonucleotides
December 14, 2022 Medical Communications
UK-based GSK has announced a partnership with American company Wave Life Sciences, valued at up to $3.3bn. The partnership will …
GSK chooses London’s West End for new headquarters
December 13, 2022 Medical Communications
GlaxoSmithKline has chosen to establish its new headquarters in London’s West End, on the corner of New Oxford Street and …
RemeGen’s RC118 granted two orphan drug designations by FDA
December 13, 2022 Medical Communications
Chinese commercial-stage biotechnology company RemeGen has announced that RC118 for injection – its latest antibody-drug conjugate (ADC) – has been …
UK Strep A death toll rises to 15
December 9, 2022 Medical Communications
Data from the UK Health Security Agency (UKHSA) show that 15 children under the age of 15 have now died …
FDA priority review given to Pfizer’s RSV vaccine for older adults
December 9, 2022 Medical Communications
Pfizer has announced that the FDA has accepted its application for a respiratory syncytial virus (RSV) vaccine for older adults, …
Biocorp receives FDA 510(k) approval for Mallya device
December 8, 2022 Medical Communications
French medical devices company, Biocorp, has received the FDA’s 510(k) approval for diabetes care device, Mallya. The device is a …
Scottish Medicines Consortium approves Bayer’s Kerendia for NHS Scotland
December 2, 2022 Medical Communications
The Scottish Medicines Consortium (SMC) has given the green light to Bayer’s Kerendia (finerenone), a chronic kidney disease (CKD) drug …
AstraZeneca and MSD launch prostate cancer awareness campaign
December 2, 2022 Medical Communications
AstraZeneca and MSD (known as Merck & Co. in the United States and Canada) have announced their collaborative global prostate …
FDA grants approval to WISE for neuromonitoring cortical strip
December 2, 2022 Medical Communications
WISE, a medical equipment manufacturer based in Italy, has obtained FDA approval for its single-use medical device WISE Cortical Strip …
Pulmonx secure Japanese approval for Zephyr Valve for COPD/emphysema
December 1, 2022 Medical Communications
Pulmonx, a US-based medical technology company, has secured approval from the Japanese Ministry of Health, Labour, and Welfare (MHLW) for …
FDA approves Ferring’s first-in-class microbiota-based live biotherapeutic
December 1, 2022 Medical Communications
Switzerland-based Ferring Pharmaceuticals announced the FDA has approved its biotherapeutic REBYOTA®, indicated for the prevention of recurrence of Clostridioides difficile …
Bayer and Orion Corporation-developed prostate cancer treatment approved by NHS England and MHRA
November 28, 2022 Medical Communications
NHS England and the Medicines and Healthcare products Regulatory Agency have approved a prostate cancer treatment, developed jointly by Bayar …
Brainomix and Pixyl partner to offer multiple sclerosis treatment
November 28, 2022 Medical Communications
In a new partnership, UK-based medical software developer Brainomix will distribute Neuro.MS ‒ French medical imaging company Pixyl’s Software as …
NHS nurses strike announced for 15 and 20 December
November 25, 2022 Medical Communications
The Royal College of Nursing (RCN) has announced strikes on 15 and 20 December in a continuing pay dispute with …
Latest content
Acumentis CEO Herspiegel steps down as Burden assumes role
October 27, 2026
October 26, 2026
